Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation. - Wikidata - wikimedia - TriplyDB

Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.

Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.

http://www.wikidata.org/entity/Q36095781

about

Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayers Hallmarks of cancer and AU-rich elements Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus.Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin Regulation of the mRNA half-life in breast cancer Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements.Coordinated expression of tristetraprolin post-transcriptionally attenuates mitogenic induction of the oncogenic Ser/Thr kinase Pim-1.Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy.EGF activates TTP expression by activation of ELK-1 and EGR-1 transcription factors Suppression of laser-induced choroidal neovascularization by intravitreal injection of tristetraprolin.Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.Transcriptome sequencing reveals differences between primary and secondary hair follicle-derived dermal papilla cells of the Cashmere goat (Capra hircus).Caffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genes.Hypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells.Drosophila eyes absent is a novel mRNA target of the tristetraprolin (TTP) protein DTIS11 The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.Tristetraprolin regulation of interleukin-22 production Hsp70 is a novel posttranscriptional regulator of gene expression that binds and stabilizes selected mRNAs containing AU-rich elements.p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition.Antagonistic function of the RNA-binding protein HuR and miR-200b in post-transcriptional regulation of vascular endothelial growth factor-A expression and angiogenesis.mTOR regulates cellular iron homeostasis through tristetraprolin.Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin Gene regulation by RNA binding proteins and microRNAs in angiogenesis.Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.TIS11 family proteins and their roles in posttranscriptional gene regulation.Three Residues Make an Evolutionary Switch for Folding and RNA-Destabilizing Activity in the TTP Family of Proteins Inflammation: cytokines and RNA-based regulation.RNA binding protein, tristetraprolin in a murine model of recurrent pregnancy loss.Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.Tristetraprolin: roles in cancer and senescence.The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells.Multiple functions of tristetraprolin/TIS11 RNA-binding proteins in the regulation of mRNA biogenesis and degradation.Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis.Post-transcriptional regulation of cytokine and growth factor signaling in cancer.A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.Casein kinase 2 regulates the mRNA-destabilizing activity of tristetraprolin.The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis.Identification of DEAD-box RNA helicase 6 (DDX6) as a cellular modulator of vascular endothelial growth factor expression under hypoxia.

P2860

Q24598616-5B0AFF75-5D05-4308-9016-25FA12C846B1 Q26744134-BF8FE1ED-1C1E-4B24-9AB8-55744541FB70 Q26745683-FFF4F0B5-368A-4A98-9B65-467356BE9462 Q33668719-6B2EE524-47C3-4E63-8B83-9671BF3A7142 Q33885061-4346C6CA-EA97-45DF-80DD-22D967BC0703 Q34023658-C8FE5DBE-52D7-476E-BFB6-7A3BAD75DD49 Q34065213-FA546D9D-336D-4A17-8ADF-D1BD52B9DBCF Q34193713-BA9F39CE-7DE0-4A16-9D5A-E8DA007F19F6 Q34200816-AE645992-5F71-409A-89AE-B47AC2669484 Q34203752-30835AA7-2796-486E-AF2D-1DFDE4F65646 Q34735778-F6355FC7-1786-453E-A79D-1DE051E4483E Q34989668-EE8B556A-9B16-4A57-A7BC-F4D7A05C33CA Q34999770-0F527F58-7ACB-4A32-B641-B33D79BDA145 Q35111214-9E0A0F63-C182-4254-A188-22C3784B326E Q35210986-9C088137-F71E-4A2C-8C21-CFAA1BE6865C Q35926324-865A2AE1-305C-4E09-ACDF-8C7B30CB2C7B Q36174568-CA13B3CB-B536-417E-BEE4-7C4146C13C7A Q36184781-88F58000-F9F8-4948-B050-BA7B87F5D7BF Q36506606-69A57680-12E3-432D-BC4D-4EF305CB0808 Q36520748-70737BE8-DE7F-4E02-92E8-2611CF15D2C1 Q36620813-A6B0A6BF-EA4D-443F-9E1D-CFCCFF4C72BF Q36675850-5ED2163F-F036-47FE-A9BE-BE4CEA5CF8DA Q36727319-EF3D1457-DF0F-4E4E-86C2-E5451354B1CD Q36764284-369CFDD5-84BA-49F8-8108-71AC1A019356 Q37119721-08E58C3B-33E2-41A2-A4BD-F814714E105E Q37292351-128005D4-D9E6-4FAA-9149-7BFE67D6CD21 Q37455266-7FA96B9C-11C7-421F-8FCA-ACA1867A39F3 Q37560020-A1697E6E-B288-484C-A0F3-0C20DF65A5FB Q37687246-C38FFF46-36E3-4856-AD02-CC78C884E334 Q37705932-4705A816-6E90-45AA-8C22-C16225AC35F3 Q37990333-05C2AEB8-6954-4EA9-8BED-DFA5093C56A9 Q38012032-2F994FF4-A075-4DF2-8FC9-C6CB4EC86030 Q38042546-5814EBE0-1B75-45CB-99F9-E76F82B648F3 Q38866652-E94B398B-1E09-4C88-AA05-287927A58D59 Q39036700-8470E385-94B7-4746-8746-57ACB755B514 Q39482570-505D938D-FA55-40BF-A456-7F4A4EC388CF Q39540154-3D9CBD68-7818-4724-BC33-F5E4C7795934 Q39555596-A2C815DA-11BA-45AF-A92E-A720CF9798AC Q39843664-C00FA684-B8EB-46EA-AD88-72BDD179832D Q41832579-F1D5592D-1C7F-4A5D-8D91-D9E4C9618E2D

P2860

Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.

http://www.wikidata.org/entity/Q36095781

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Tristetraprolin inhibits Ras-d ...... rowth factor mRNA degradation.

@ast

Tristetraprolin inhibits Ras-d ...... rowth factor mRNA degradation.

@en

type

label

Tristetraprolin inhibits Ras-d ...... rowth factor mRNA degradation.

@ast

Tristetraprolin inhibits Ras-d ...... rowth factor mRNA degradation.

@en

prefLabel

Tristetraprolin inhibits Ras-d ...... rowth factor mRNA degradation.

@ast

Tristetraprolin inhibits Ras-d ...... rowth factor mRNA degradation.

@en

P1433

Q36095781-4C6A5075-F45A-4B6A-A2CF-147F78B6E458

P1476

Q36095781-33A518D2-40AD-4036-992A-9E92439BEBBE

P2093

Q36095781-5A19DC17-1151-4CFC-B895-CD4BD2590A66

Q36095781-7D086DC3-3D21-4B69-9DCB-01C83FD5CF3F

Q36095781-B8002738-981E-4C04-98AE-4592CFA00327

Q36095781-B894A41F-E21E-4823-9611-DC1DAB2E903A

Q36095781-CA7C7BFB-4065-437D-86F6-D0425CE100B2

P2860

Q36095781-07554C9F-0631-4C83-ADE3-2E8BCCAD7B41

Q36095781-0953E0B0-CFD3-4013-A779-6765D929ECA6

Q36095781-12E4EB87-C82D-4A0F-B0A6-557476241B9D

Q36095781-18140B18-383D-4F68-A975-3204C8905322

Q36095781-288055EB-84DA-4AC8-9D6C-41C0ECB15CC1

Q36095781-30C0E996-7BDD-4F3F-A2BB-EF93F3A59867

Q36095781-356E2B5D-4756-4A43-8E2C-61341D7DE2AA

Q36095781-37237C26-D97B-413B-A666-F8D0AFCB5985

Q36095781-38B8ECBD-A6B8-4DB8-9F2A-29405A7DC644

Q36095781-3DDDA265-86CD-4BFC-8DC2-B8DA446E1743

P304

Q36095781-3F6DC308-120B-402C-8575-92498D37C78F

P31

Q36095781-6AEFF69E-DAF4-4F08-8302-3CDD11A7D5A6

P356

Q36095781-08A20062-537B-472C-A657-D136A4B51482

P433

Q36095781-8D37ABBB-4600-4CF8-9879-6362C1DAD2EF

P478

Q36095781-D5AE2F20-5E59-4F9A-9767-4983B3781586

P577

Q36095781-F70B5C25-268C-46B8-B6CC-77763864E147

P698

Q36095781-76A4F32E-E123-4030-A060-8BD0F2C1A8E5

P921

Q36095781-A28AAF49-1A8F-431F-A190-01A44F084911

P932

Q36095781-09FD53EE-18AC-4D4C-81DD-3B5524A32BE4

P356

MBC.E07-06-0570

P1433

Molecular Biology of the Cell

P1476

Tristetraprolin inhibits Ras-d ...... rowth factor mRNA degradation.

@en

P2093

Cercina Onesto

http://www.w3.org/2001/XMLSchema#string

Christoph Moroni

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Stebe

http://www.w3.org/2001/XMLSchema#string

Gilles Pagès

http://www.w3.org/2001/XMLSchema#string

Khadija Essafi-Benkhadir

http://www.w3.org/2001/XMLSchema#string

P2860

Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L

Poly(A)-binding protein-interacting protein 2, a strong regulator of vascular endothelial growth factor mRNA.

Molecular and biological properties of vascular endothelial growth factor.

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy.

Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo.

Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: a zinc-dependent mRNA binding protein affected by posttranslational modifications.

Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element

P304

4648-4658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1091/MBC.E07-06-0570

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17855506

http://www.w3.org/2001/XMLSchema#string

P921

P932

2043565

http://www.w3.org/2001/XMLSchema#string